Showing results (6331-6340 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|January 8, 2015
Early life stress in depressive patients: role of glucocorticoid and mineralocorticoid receptors and of hypothalamic-pituitary-adrenal axis activityMario Francisco Juruena, Cristiane Von Werne Baes, Itiana Castro Menezes, et al.Current Pharmaceutical Design|January 8, 2015
Childhood maltreatment and stress-related psychopathology: the epigenetic memory hypothesisPierre-Eric Lutz, Daniel Almeida, Laura M Fiori, et al.Current Pharmaceutical Design|January 8, 2015
Early-life stress and psychiatric disorders: epidemiology, neurobiology and innovative pharmacological targetsA Ventriglio, A Gentile, R J Baldessarini, et al.Current Pharmaceutical Design|October 25, 2014
Poly-pharmacy among the elderly: analyzing the co-morbidity of hypertension and diabetesMichela Franchini, Stefania Pieroni, Loredana Fortunato, et al.Current Pharmaceutical Design|October 25, 2014
Difference in blood pressure measurements between arms: methodological and clinical implicationsChristopher E ClarkCurrent Pharmaceutical Design|October 25, 2014
Non-invasive estimation of aortic blood pressures: a close look at current devices and methodsSandrine Millasseau, Davide AgnolettiCurrent Pharmaceutical Design|October 25, 2014
Blood pressure measurement: lessons learned from our ancestorsMarianna Karamanou, Theodore G Papaioannou, Gregory Tsoucalas, et al.Current Pharmaceutical Design|October 25, 2014
Combining oncolytic virotherapy and cytotoxic therapies to fight cancerCristina Fillat, Maria Victoria Maliandi, Ana Mato-Berciano, et al.Current Pharmaceutical Design|October 25, 2014
Anti-metastatics: an overview of drug candidates in current pipelinesAnne Schaap-Nutt, Dane A Thyssen, David W Drell, et al.Current Pharmaceutical Design|October 25, 2014
NCRNA combined therapy as future treatment option for cancerCornelia Braicu, Cristina Catana, George A Calin, et al.Pageof 1,008